BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32252788)

  • 1. Perceived barriers to randomised controlled trials in breast reconstruction: obstacle to trial initiation or opportunity to resolve? A qualitative study.
    Davies G; Mills N; Holcombe C; Potter S;
    Trials; 2020 Apr; 21(1):316. PubMed ID: 32252788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to be BRAVE: is educating surgeons the key to unlocking the potential of randomised clinical trials in surgery? A qualitative study.
    Potter S; Mills N; Cawthorn SJ; Donovan J; Blazeby JM
    Trials; 2014 Mar; 15():80. PubMed ID: 24628821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iBRA (implant breast reconstruction evaluation) study: protocol for a prospective multi-centre cohort study to inform the feasibility, design and conduct of a pragmatic randomised clinical trial comparing new techniques of implant-based breast reconstruction.
    Potter S; Conroy EJ; Williamson PR; Thrush S; Whisker LJ; Skillman JM; Barnes NL; Cutress RI; Teasdale EM; Mills N; Mylvaganam S; Branford OA; McEvoy K; Jain A; Gardiner MD; Blazeby JM; Holcombe C;
    Pilot Feasibility Stud; 2016; 2():41. PubMed ID: 27965859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best-BRA (Is subpectoral or prepectoral implant placement best in immediate breast reconstruction?): a protocol for a pilot randomised controlled trial of subpectoral versus prepectoral immediate implant-based breast reconstruction in women following mastectomy.
    Roberts K; Mills N; Metcalfe C; Lane A; Clement C; Hollingworth W; Taylor J; Holcombe C; Skillman J; Fairhurst K; Whisker L; Cutress R; Thrush S; Fairbrother P; Potter S
    BMJ Open; 2021 Nov; 11(11):e050886. PubMed ID: 34848516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'The trial is owned by the team, not by an individual': a qualitative study exploring the role of teamwork in recruitment to randomised controlled trials in surgical oncology.
    Strong S; Paramasivan S; Mills N; Wilson C; Donovan JL; Blazeby JM
    Trials; 2016 Apr; 17(1):212. PubMed ID: 27113592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of implant loss after immediate implant-based breast reconstruction: qualitative study.
    Mahoney B; Walklet E; Bradley E; Thrush S; Skillman J; Whisker L; Barnes N; Holcombe C; Potter S
    BJS Open; 2020 Jun; 4(3):380-390. PubMed ID: 32181587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials.
    Donovan JL; Paramasivan S; de Salis I; Toerien M
    Trials; 2014 Jan; 15():5. PubMed ID: 24393291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the provision and practice of implant-based breast reconstruction in the UK: Results from the iBRA national practice questionnaire.
    Mylvaganam S; Conroy E; Williamson PR; Barnes NLP; Cutress RI; Gardiner MD; Jain A; Skillman JM; Thrush S; Whisker LJ; Blazeby JM; Potter S; Holcombe C; ;
    Breast; 2017 Oct; 35():182-190. PubMed ID: 28768227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.
    Rooshenas L; Elliott D; Wade J; Jepson M; Paramasivan S; Strong S; Wilson C; Beard D; Blazeby JM; Birtle A; Halliday A; Rogers CA; Stein R; Donovan JL; ; ; ; ; ;
    PLoS Med; 2016 Oct; 13(10):e1002147. PubMed ID: 27755555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial.
    Dikmans RE; Negenborn VL; Bouman MB; Winters HA; Twisk JW; Ruhé PQ; Mureau MA; Smit JM; Tuinder S; Eltahir Y; Posch NA; van Steveninck-Barends JM; Meesters-Caberg MA; van der Hulst RR; Ritt MJ; Mullender MG
    Lancet Oncol; 2017 Feb; 18(2):251-258. PubMed ID: 28012977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey.
    Mylvaganam S; Conroy EJ; Williamson PR; Barnes NLP; Cutress RI; Gardiner MD; Jain A; Skillman JM; Thrush S; Whisker LJ; Blazeby JM; Potter S; Holcombe C; ;
    Eur J Surg Oncol; 2018 May; 44(5):708-716. PubMed ID: 29472041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey].
    Guo R; Xiu BQ; Su YH; Wang J; Zhang Q; Chi WR; Li L; Yang BL; Zhang YY; Cao AY; Shao ZM; Wu J
    Zhonghua Wai Ke Za Zhi; 2019 Aug; 57(8):616-621. PubMed ID: 31422632
    [No Abstract]   [Full Text] [Related]  

  • 14. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practice and barriers of mesh-assisted implant-based breast reconstruction in China: A nationwide cross-sectional survey of 110 hospitals.
    Guo R; Li L; Su Y; Xiu B; Zhang Q; Wang J; Chi W; Yang B; Zhang Y; Cao A; Shao Z; Wu J
    Eur J Surg Oncol; 2020 Jan; 46(1):65-70. PubMed ID: 31519428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using digital tools in the recruitment and retention in randomised controlled trials: survey of UK Clinical Trial Units and a qualitative study.
    Blatch-Jones A; Nuttall J; Bull A; Worswick L; Mullee M; Peveler R; Falk S; Tape N; Hinks J; Lane AJ; Wyatt JC; Griffiths G
    Trials; 2020 Apr; 21(1):304. PubMed ID: 32245506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social validity of randomised controlled trials in health services research and intellectual disabilities: a qualitative exploration of stakeholder views.
    Robotham D; King M; Canagasabey A; Inchley-Mort S; Hassiotis A
    Trials; 2011 Jun; 12():144. PubMed ID: 21658215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgeons' and methodologists' perceptions of utilising an expertise-based randomised controlled trial design: a qualitative study.
    Cook JA; Campbell MK; Gillies K; Skea Z
    Trials; 2018 Sep; 19(1):478. PubMed ID: 30189868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embedding qualitative research in randomised controlled trials to improve recruitment: findings from two recruitment optimisation studies of orthopaedic surgical trials.
    Scantlebury A; McDaid C; Brealey S; Cook E; Sharma H; Ranganathan A; Adamson J;
    Trials; 2021 Jul; 22(1):461. PubMed ID: 34274006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - Quanti-Qualitative Appointment Timing.
    Paramasivan S; Strong S; Wilson C; Campbell B; Blazeby JM; Donovan JL
    Trials; 2015 Mar; 16():88. PubMed ID: 25873096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.